|

HRS-4642;nab-paclitaxel; gemcitabine Clinical Trials

1 actively recruiting trial

Pipeline

Phase 1/2: 1

Top Sponsors

  • Shanghai Hengrui Pharmaceutical Co., Ltd.1

Indications

  • Locally Advanced or Metastatic Pancreatic Cancer With1
  • Cancer1

Other1 trial

HRS-4642 Combination With Other Antitumor Therapies in Patients With Solid Tumors
Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.